Sandra A. Calarota
Pavia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay.
Journal: Journal of immunology research
Published: July 24, 2018
Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates.
Journal: Molecules (Basel, Switzerland)
Published: May 25, 2017
Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects.
Journal: Human vaccines & immunotherapeutics
Published: July 09, 2016
T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: April 20, 2015
Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: March 09, 2015
Neutrophil CD64 expression: a reliable diagnostic marker of infection in advanced cancer patients?
Journal: The new microbiologica
Published: January 26, 2015
Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: March 20, 2014
Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays.
Journal: Clinical & developmental immunology
Published: June 06, 2013
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
Journal: PloS one
Published: June 20, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
Journal: PloS one
Published: January 10, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026